{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:30:21Z","timestamp":1787020221148,"version":"build-2736575974"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T00:00:00Z","timestamp":1735257600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T00:00:00Z","timestamp":1735257600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-024-10376-2","type":"journal-article","created":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T15:17:34Z","timestamp":1735312654000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Prevalence of overt and occult hepatitis B viral infection among pregnant women attending antenatal clinics in Edo state university teaching hospital Auchi, Nigeria"],"prefix":"10.1186","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3820-3631","authenticated-orcid":false,"given":"Bukhari Isah","family":"Shuaib","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amina","family":"Momodu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johnsolomon Eghosa","family":"Ohenhen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ijeoma Evangeline","family":"Umeche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Musa Abidemi","family":"Muhibi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,27]]},"reference":[{"key":"10376_CR1","unstructured":"World Health Organization. Global hepatitis report 2024: action for access in low- and middle-income countries. Geneva: World Health Organization. 2024. Available from: https:\/\/www.who.int\/publications\/i\/item\/9789240091672. Accessed 8 July 2024."},{"key":"10376_CR2","unstructured":"World Health Organization. Guidelines for the prevention, diagnosis, care and treatment for people with chronic hepatitis B infection. Geneva: World Health Organization. 2024. Available from: https:\/\/www.who.int\/publications\/i\/item\/9789240090903. Accessed 8 July 2024."},{"key":"10376_CR3","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s44263-023-00026-1","volume":"1","author":"CW Spearman","year":"2023","unstructured":"Spearman CW, Andersson MI, Bright B, et al. A new approach to prevent, diagnose, and treat hepatitis B in Africa. BMC Global Public Health. 2023;1:24. https:\/\/doi.org\/10.1186\/s44263-023-00026-1.","journal-title":"BMC Global Public Health"},{"key":"10376_CR4","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1186\/s12879-024-09839-3","volume":"24","author":"TG Wondmeneh","year":"2024","unstructured":"Wondmeneh TG, Mekonnen AT. Epidemiology of hepatitis B virus infection among pregnant women in Africa: a systematic review and meta-analysis. BMC Infect Dis. 2024;24:921. https:\/\/doi.org\/10.1186\/s12879-024-09839-3.","journal-title":"BMC Infect Dis"},{"key":"10376_CR5","doi-asserted-by":"publisher","unstructured":"Shenge JA, Osiowy C. Rapid diagnostics for hepatitis B and C viruses in low- and middle-income countries. Front Virol. 2021; 1:742722. https:\/\/doi.org\/10.3389\/fviro.2021.742722. Available from: https:\/\/www.frontiersin.org\/journals\/virology\/articles\/10.3389\/fviro.2021.742722","DOI":"10.3389\/fviro.2021.742722"},{"key":"10376_CR6","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1186\/s12879-021-06800-6","volume":"21","author":"BI Ajuwon","year":"2021","unstructured":"Ajuwon BI, Yujuico I, Roper K, et al. Hepatitis B virus infection in Nigeria: a systematic review and meta-analysis of data published between 2010 and 2019. BMC Infect Dis. 2021;21:1120. https:\/\/doi.org\/10.1186\/s12879-021-06800-6.","journal-title":"BMC Infect Dis"},{"issue":"29","key":"10376_CR7","doi-asserted-by":"publisher","first-page":"3793","DOI":"10.3748\/wjg.v28.i29.3793","volume":"28","author":"B Gnyawali","year":"2022","unstructured":"Gnyawali B, Pusateri A, Nickerson A, Jalil S, Mumtaz K. Epidemiologic and socioeconomic factors impacting hepatitis B virus and related hepatocellular carcinoma. World J Gastroenterol. 2022;28(29):3793\u2013802. https:\/\/doi.org\/10.3748\/wjg.v28.i29.3793.","journal-title":"World J Gastroenterol"},{"issue":"4","key":"10376_CR8","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1016\/j.jhep.2020.05.042","volume":"73","author":"LY Mak","year":"2020","unstructured":"Mak LY, Seto WK, Cheung KS. Occult Hepatitis B infection and hepatocellular carcinoma: epidemiology, virology, hepatocarcinogenesis and clinical significance. J Hepatol. 2020;73(4):952\u201364.","journal-title":"J Hepatol"},{"issue":"4","key":"10376_CR9","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/j.jhep.2008.07.014","volume":"49","author":"G Raimondo","year":"2019","unstructured":"Raimondo G, Allain JP, Brunetto MR. Statements from the Taormina expert meeting on occult hepatitis B virus infection. J Hepatol. 2019;49(4):652\u20137.","journal-title":"J Hepatol"},{"issue":"7","key":"10376_CR10","first-page":"1587","volume":"41","author":"J Lou","year":"2021","unstructured":"Lou J, Zhao X, Zhang L, et al. Occult Hepatitis B infection in Chinese patients with chronic liver diseases and its association with hepatocellular carcinoma. Liver Int. 2021;41(7):1587\u201396.","journal-title":"Liver Int"},{"key":"10376_CR11","doi-asserted-by":"crossref","unstructured":"Oluyinka OO, Tong HV, Bui TM. Occult Hepatitis B virus infection among Nigerian blood donors and hepatitis B virus transmission risks. PLoS ONE. 2015;10(7).","DOI":"10.1371\/journal.pone.0131912"},{"key":"10376_CR12","doi-asserted-by":"publisher","DOI":"10.1007\/s42399-022-01359-y","author":"A Usman","year":"2022","unstructured":"Usman A, Shuaib BI, Musa BOP, Awwal S, Akogwu S. Seroprevalence of occult hepatitis B virus infection using anti-HBc and nucleic acid amplification (HBV DNA) technique in a resource-limited setting: a systematic review and meta-analysis of Nigerian literature. SN Compr Clin Med. 2022. https:\/\/doi.org\/10.1007\/s42399-022-01359-y.","journal-title":"SN Compr Clin Med"},{"key":"10376_CR13","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1186\/s12875-023-02157-8","volume":"24","author":"BO Olakunde","year":"2023","unstructured":"Olakunde BO, Adeyinka DA, Olakunde OA, et al. Barriers to hepatitis B virus screening of pregnant women in primary healthcare centers in Nigeria: health workers\u2019 perspective. BMC Prim Care. 2023;24:209. https:\/\/doi.org\/10.1186\/s12875-023-02157-8.","journal-title":"BMC Prim Care"},{"issue":"3","key":"10376_CR14","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s40471-021-00273-6","volume":"8","author":"A Jaquet","year":"2021","unstructured":"Jaquet A, Muula G, Ekouevi DK, Wandeler G. Elimination of viral hepatitis in low and middle-income countries: epidemiological research gaps. Curr Epidemiol Rep. 2021;8(3):89\u201396. https:\/\/doi.org\/10.1007\/s40471-021-00273-6.","journal-title":"Curr Epidemiol Rep"},{"issue":"7","key":"10376_CR15","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.4254\/wjh.v14.i7.1333","volume":"14","author":"ZNA Said","year":"2022","unstructured":"Said ZNA, El-Sayed MH. Challenge of managing hepatitis B virus and hepatitis C virus infections in resource-limited settings. World J Hepatol. 2022;14(7):1333\u201343. https:\/\/doi.org\/10.4254\/wjh.v14.i7.1333. PMID: 36158908; PMCID: PMC9376770.","journal-title":"World J Hepatol"},{"key":"10376_CR16","first-page":"47","volume":"191","author":"BO Olakunde","year":"2021","unstructured":"Olakunde BO, Adeyinka DA, Olakunde OA. Hepatitis B virus infection in Nigeria: a systematic review and meta-analysis of data published between 2010 and 2019. Public Health. 2021;191:47\u201356.","journal-title":"Public Health"},{"issue":"4","key":"10376_CR17","first-page":"662","volume":"3","author":"E Nna","year":"2014","unstructured":"Nna E, Mbamalu C, Ekejindu I. Prevalence of occult hepatitis B virus infection among blood donors in Southeastern Nigeria. Pathogens. 2014;3(4):662\u201373.","journal-title":"Pathogens"},{"issue":"2","key":"10376_CR18","doi-asserted-by":"publisher","first-page":"163","DOI":"10.4103\/1119-3077.151035","volume":"18","author":"BM Musa","year":"2015","unstructured":"Musa BM, Bussell S, Borodo MM. Prevalence of hepatitis B virus infection in Nigeria, 2000\u20132013: a systematic review and meta-analysis. Niger J Clin Pract. 2015;18(2):163\u201372.","journal-title":"Niger J Clin Pract"},{"key":"10376_CR19","unstructured":"Decie S, Lewis SM. Practical haematology. 9th ed. Churchill Livingstone; 1999."},{"key":"10376_CR20","unstructured":"Burtis C, Ashwood E, Bruns D. Tietz textbook of clinical chemistry and molecular diagnostics. 5th ed. Elsevier Saunders; 2013."},{"issue":"3","key":"10376_CR21","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.jcv.2009.06.001","volume":"45","author":"RB Takkenberg","year":"2009","unstructured":"Takkenberg RB, Zaaijer HL, Molenkamp R, de Man RA, Schalm SW. Detection of hepatitis B virus DNA using real-time polymerase chain reaction: implications for therapy and monitoring. J Clin Virol. 2009;45(3):196\u2013200.","journal-title":"J Clin Virol"},{"key":"10376_CR22","doi-asserted-by":"publisher","unstructured":"Akinbami A, Badiru M, Uche E, Onyekwere C, Ismail K, Olowoselu O et al. The prevalence of Occult Hepatitis B infection among blood donors in Lagos, Nigeria. Niger Med J 2019 Jan-Feb;60(1):22\u20136. https:\/\/doi.org\/10.4103\/nmj.NMJ_29_19","DOI":"10.4103\/nmj.NMJ_29_19"},{"issue":"2","key":"10376_CR23","first-page":"182","volume":"18","author":"CG Anaedobe","year":"2015","unstructured":"Anaedobe CG, Fowotade A, Omoruyi CE. Mother-to-child transmission of hepatitis B virus infection in Nigeria: a review. Niger J Clin Pract. 2015;18(2):182\u20137.","journal-title":"Niger J Clin Pract"},{"issue":"3","key":"10376_CR24","first-page":"512","volume":"68","author":"H Zhang","year":"2018","unstructured":"Zhang H, Li Q, Sun J. First-time pregnancies and increased risk of HBV transmission: insights into immune response and exposure history. J Hepatol. 2018;68(3):512\u201320.","journal-title":"J Hepatol"},{"key":"10376_CR25","first-page":"46","volume":"102","author":"CF de Gascun","year":"2018","unstructured":"de Gascun CF, Carr MJ, Knowles SJ. Prevalence of hepatitis B virus infection in pregnant women attending antenatal clinics in the Republic of Ireland: 2008\u20132012. J Clin Virol. 2018;102:46\u201350.","journal-title":"J Clin Virol"},{"issue":"2","key":"10376_CR26","first-page":"74","volume":"29","author":"L Zhao","year":"2019","unstructured":"Zhao L, Wang Y, Liu J. Alcohol consumption and risk of liver cancer: a dose-response meta-analysis of prospective cohort studies. J Epidemiol. 2019;29(2):74\u201380.","journal-title":"J Epidemiol"},{"issue":"7","key":"10376_CR27","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1097\/MCG.0000000000001077","volume":"49","author":"J Chen","year":"2015","unstructured":"Chen J, Zhang Y, Cai L. Cigarette smoking and liver diseases: chronic liver diseases. J Clin Gastroenterol. 2015;49(7):573\u20139.","journal-title":"J Clin Gastroenterol"},{"issue":"2","key":"10376_CR28","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.jhep.2007.11.011","volume":"48","author":"G Fattovich","year":"2008","unstructured":"Fattovich G, Bortolotti F, Donato F. Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors. J Hepatol. 2008;48(2):335\u201352. https:\/\/doi.org\/10.1016\/j.jhep.2007.11.011.","journal-title":"J Hepatol"},{"key":"10376_CR29","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1743-422X-9-16","volume":"9","author":"JY Zhou","year":"2012","unstructured":"Zhou JY, Zhang L, Li L, Gu GY, Zhou YH, Chen JH. High hepatitis B virus load is associated with hepatocellular carcinomas development in Chinese chronic hepatitis B patients: a case control study. Virol J. 2012;9:16. https:\/\/doi.org\/10.1186\/1743-422X-9-16.","journal-title":"Virol J"},{"issue":"3","key":"10376_CR30","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/j.jhep.2014.04.036","volume":"61","author":"T Pollicino","year":"2014","unstructured":"Pollicino T, Raimondo G. Occult Hepatitis B infection. J Hepatol. 2014;61(3):688\u20139. https:\/\/doi.org\/10.1016\/j.jhep.2014.04.036.","journal-title":"J Hepatol"},{"issue":"5 Suppl","key":"10376_CR31","doi-asserted-by":"publisher","first-page":"S72","DOI":"10.1002\/hep.22884","volume":"49","author":"CJ Chen","year":"2009","unstructured":"Chen CJ, Yang HI, Iloeje UH, et al. Hepatitis B virus DNA levels and outcomes in chronic hepatitis B. Hepatology. 2009;49(5 Suppl):S72\u201384. https:\/\/doi.org\/10.1002\/hep.22884.","journal-title":"Hepatology"},{"issue":"4","key":"10376_CR32","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1002\/hep.29800","volume":"67","author":"NA Terrault","year":"2018","unstructured":"Terrault NA, Lok ASF, McMahon BJ, et al. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology. 2018;67(4):1560\u201399. https:\/\/doi.org\/10.1002\/hep.29800.","journal-title":"Hepatology"},{"issue":"8","key":"10376_CR33","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/s1473-3099(02)00345-6","volume":"2","author":"M Torbenson","year":"2002","unstructured":"Torbenson M, Thomas DL. Occult Hepatitis B. Lancet Infect Dis. 2002;2(8):479\u201386. https:\/\/doi.org\/10.1016\/s1473-3099(02)00345-6.","journal-title":"Lancet Infect Dis"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-024-10376-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-024-10376-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-024-10376-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T16:24:33Z","timestamp":1735316673000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-024-10376-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,27]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["10376"],"URL":"https:\/\/doi.org\/10.1186\/s12879-024-10376-2","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,27]]},"assertion":[{"value":"29 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the hospital research ethics committee of Edo State University, Uzarue, Nigeria (ethical approval number: EDSUREC24\/0010). Informed consent was obtained from all the participants in accordance with Helsinki Declaration of 1975, as revised in 2000; voluntariness and strict confidentiality were maintained throughout the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial"}}],"article-number":"1468"}}